European Disease Progression Monitor: Edition 5

European Disease Progression Monitor: Edition 5

COVID-19 EU progression monitor

lockdown exit strategies in EU

lockdown transition plan

COVID-19 death rate EU

tracking the pandemic

control phase

French data

U.K. numbers have stabilised

Overview of treatments

Disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition 4

Related Insights

Life Sciences & Pharma

Presentations

European Disease Progression Monitor: Edition 1

March 27, 2020

L.E.K. has identified 5 phases of disease progression, defined by the death rate, with the possibility of repeated cycles if countries suffer viral…

MedTech

Executive Insights

Impact of COVID-19 on the Australian MTP Sector

August 21, 2020

The COVID-19 crisis has had a strongly negative impact on the MTP sector, as it has on many other parts of the Australian economy.

Life Sciences & Pharma

Published Articles

2020 Trends In Pharma Asset Licensing And Deal Terms: A Survey Of Key Decision-Makers

September 24, 2020

In this article, we describe some key drivers of asset value, as well as areas of alignment and divergence between parties on deal expectations.

MedTech

Executive Insights

COVID-19 and the Acceleration of Digital Health in APAC

April 23, 2020

Healthcare stakeholders are implementing drastic measures, including swift deployment of digital health tools, in an effort to curb the spread of the…

Life Sciences & Pharma

Published Articles

How to Approach an Increasingly Challenging and Subjective Japanese Pricing Environment

October 8, 2020

Japan remains on balance an attractive pharmaceutical market, with favorable volume dynamics, generally attractive pricing and broad and unfettered market…

Organization & Performance

Executive Insights

Agile Transformation Part 2: Tackling the Challenges of Scaling

May 14, 2020

We share our experience of working with large corporations to develop and execute agile transformation programmes